KFF/Washington Post Poll Looks at Parents’ Trust in Children’s Health Content on Social Media, And Unfounded Claims About Abortion Pill Safety Follow FDA Approval of Generic Version – The Monitor

This volume shares findings from the KFF/The Washington Post Survey of Parents about exposure to and trust in children’s health content on social media, along with misleading claims following the approval of a generic version of mifepristone, reports of autism possibly being added to the Vaccine Injury Compensation Program, and patients using AI chatbots to…

Read More

The Future of Drug Discovery is 3D

Improving the identification and validation of disease-specific drug targets in a cell-type and patient-specific manner early on will not only reduce the failure rate and cost that is so inherent in current drug development processes but also allow the development of more effective precision medicines, improving patient outcomes. The post The Future of Drug Discovery…

Read More

Cancer Is on the Rise in Younger Adults: What Is the Healthcare Industry Doing About It?

Cancer rates are climbing among younger Americans, and healthcare leaders are calling for earlier screenings, more convenient testing options and expanded health plan coverage to help catch cases before they’re fatal. From at-home tests to multi-cancer detection tools, stakeholders across the industry are working to boost access to early detection. The post Cancer Is on…

Read More